Manipal Health Enterprises Lists at 11% Premium, Strong Market Debut on BSE

Manipal Health Enterprises made a strong market debut on Wednesday, listing at an 11 per cent premium to the issue price on the BSE, with its stock trading at ₹651 level.

Manipal Health Enterprises Lists at 11% Premium on BSE

The stock began trading at ₹655 against the IPO price of ₹590 on the BSE, while on the NSE, it listed at ₹652, up 10.5 per cent.

The stock later moderated to trade between ₹635 and ₹662 and was at around ₹651 at the time of writing.

Market Experts Weigh in on the Listing

Shivani Nyati, Head of Wealth at Swastika Investmart, said Manipal Health Enterprises’ 11 per cent listing premium reflected healthy investor demand, but added that the stock is trading at a premium valuation with limited margin of safety.

She advised allotted investors to continue holding the stock, while fresh investors should wait for better entry levels or further debt reduction before buying.

Nyati also advised maintaining a stop-loss at ₹620 to protect listing gains.

Market Impact and Details

• The company’s ₹9,275 crore initial public offering was subscribed 4.92 times overall.
• The issue received bids for 44,30,73,025 shares against 9,00,88,286 shares on offer, according to NSE data.
• The qualified institutional buyers’ portion was subscribed 8.25 times, while the non-institutional investors’ category was subscribed 1.02 times.
• The retail investors’ portion was subscribed 93 per cent.
• Ahead of the IPO, Manipal Health raised ₹4,167 crore from anchor investors, including Abu Dhabi Investment Authority and Allianz Global Investors Fund.

Key Takeaways

• Manipal Health Enterprises listed at an 11 per cent premium to the issue price on the BSE.
• The company plans to use ₹5,378 crore from the fresh issue to repay or prepay borrowings of its subsidiary, Manipal Hospitals Pvt. Ltd.
• The company operates a pan-India network of multispecialty hospitals offering services ranging from outpatient care to tertiary and quaternary interventions.

FAQs

What is the listing price of Manipal Health Enterprises stock?

The stock is trading at ₹651 level.

How much was the initial public offering of Manipal Health Enterprises?

The company’s ₹9,275 crore initial public offering was subscribed 4.92 times overall.

What is the company planning to use the fresh issue proceeds for?

The company plans to use ₹5,378 crore from the fresh issue to repay or prepay borrowings of its subsidiary, Manipal Hospitals Pvt. Ltd.

Conclusion

Manipal Health Enterprises made a strong market debut, listing at an 11 per cent premium to the issue price on the BSE. The company plans to use the fresh issue proceeds to repay or prepay borrowings of its subsidiary, Manipal Hospitals Pvt. Ltd. Investors should monitor upcoming quarterly results to assess the sustainability of margins amid competitive pricing pressure. We recommend that fresh investors wait for better entry levels or further debt reduction before buying, while allotted investors can continue to hold the stock.